Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer

Tolsotogo St., Saint Petersburg 197022, RussiaBackground. Prostate cancer (PCa) of a high and very high risk is a potentially fatal disease that requires an active multimodal approach, including the use of neoadjuvant drug treatment. As option for this treatment is neoadjuvant chemohormonal therapy...

Full description

Bibliographic Details
Main Authors: M. V. Berkut, A. S. Artemjeva, S. A. Reva, S. S. Tolmachev, S. B. Petrov, A. K. Nosov
Format: Article
Language:Russian
Published: ABV-press 2020-04-01
Series:Onkourologiâ
Subjects:
Online Access:https://oncourology.abvpress.ru/oncur/article/view/999